Overcoming challenges in the diagnosis and treatment of myasthenia gravis.

about

Report on the 3rd Ottawa International Conference on Neuromuscular Biology, Disease and Therapy - September 24-26, 2015, Ottawa, Canada.Clinical and CN-SFEMG evaluation of neostigmine test in myasthenia gravis.

P2860

Q30355125-9F1644D4-CD17-41D5-B40D-7500F1170AF6 Q48250641-666A6B71-389A-41AD-93AC-1B245F162F6B

P2860

Overcoming challenges in the diagnosis and treatment of myasthenia gravis.

Item

http://www.wikidata.org/entity/Q38671442

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Overcoming challenges in the diagnosis and treatment of myasthenia gravis.

@en

type

Item

label

Overcoming challenges in the diagnosis and treatment of myasthenia gravis.

@en

prefLabel

Overcoming challenges in the diagnosis and treatment of myasthenia gravis.

@en

P1476

Overcoming challenges in the diagnosis and treatment of myasthenia gravis.

@en

P2093

Amelia Evoli

http://www.w3.org/2001/XMLSchema#string

Emanuela Bartoccioni

http://www.w3.org/2001/XMLSchema#string

P2860

IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis

Is thymectomy in non-thymomatous myasthenia gravis of any benefit?

Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis

Pyridostigmine but not 3,4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle-specific kinase autoantibody

The function of cortactin in the clustering of acetylcholine receptors at the vertebrate neuromuscular junction

Lrp4 is a receptor for Agrin and forms a complex with MuSK

Agrin binds to the N-terminal region of Lrp4 protein and stimulates association between Lrp4 and the first immunoglobulin-like domain in muscle-specific kinase (MuSK)

Lrp4 is a retrograde signal for presynaptic differentiation at neuromuscular synapses

Effects of the ß2-adrenoceptor agonist, albuterol, in a mouse model of anti-MuSK myasthenia gravis

Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America.

P304

157-168

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/1744666X.2016.1110487

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Raffaele Iorio

P577

2015-12-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26675896

http://www.w3.org/2001/XMLSchema#string

P921

myasthenia gravis

Overcoming challenges in the diagnosis and treatment of myasthenia gravis.

about

P2860

P2860

Overcoming challenges in the diagnosis and treatment of myasthenia gravis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921